Boston Scientific (BSX) Land & Improvements (2025 - 2026)
Boston Scientific's (BSX) quarterly Land & Improvements came in at $188.0 million in Q1 2026, up 8.67% quarter-over-quarter from $173.0 million in Q4 2025.
Boston Scientific (BSX) Land & Improvements (2025 - 2026) Analysis & Trends
Boston Scientific has disclosed Land & Improvements across 2 years of filings, most recently posting $188.0 million for Q1 2026.
- Land & Improvements for Q1 2026 came in at $188.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $188.0 million (changed N/A YoY), and the FY2025 annual result was $173.0 million, changed N/A from the prior year.
- Land & Improvements came in at $188.0 million for Q1 2026 at Boston Scientific, up from $173.0 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $188.0 million in Q1 2026 to a low of $173.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.80 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 188.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 112.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188.00 Mn |
| Dec 31, 2025 | 173.00 Mn |